Development of Non-Pathogenic Staphylococci as Vaccine Delivery Vehicles

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/978-3-662-07548-7_4
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Surface display of a functional single-chain Fv antibody on staphylococci

  1996cited by this paper
• A combinatorial library of an α-helical bacterial receptor domain

  1995cited by this paper
• Surface display compared to periplasmic expression of a malarial antigen in Salmonella typhimurium and its implications for immunogenicity.

  1995cited by this paper
• Hydrophobicity engineering to facilitate surface display of heterologous gene products on Staphylococcus xylosus.

  1995cited by this paper
• Structure of the cell wall anchor of surface proteins in Staphylococcus aureus.

  1995cited by this paper
• Cell surface display of recombinant proteins on Staphylococcus carnosus

  1995cited by this paper
• Human T-helper cell recognition of an immunodominant epitope of HIV-1 gp120 expressed on the surface of Streptococcus gordonii.

  1994cited by this paper
• Recombinant vaccine delivery systems and encoded vaccines.

  1994cited by this paper
• Live bacterial vaccines: environmental aspects.

  1994cited by this paper
• Proteolytic cleavage and cell wall anchoring at the LPXTG motif of surface proteins in Gram‐positive bacteria

  1994cited by this paper
• Mucosal immunity to infection with implications for vaccine development.

  1994cited by this paper
• Evidence for importance of the Staphylococcus hyicus lipase pro-peptide in lipase secretion, stability and activity.

  1994cited by this paper
• Biochemical properties of a novel metalloprotease from Staphylococcus hyicus subsp. hyicus involved in extracellular lipase processing

  1994cited by this paper
• Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine

  1993cited by this paper
• Plasmodium falciparum: the immune response in rabbits to the clustered asparagine-rich protein (CARP) after immunization in Freund's adjuvant or immunostimulating complexes (ISCOMs).

  1993cited by this paper
• Cell-surface display of heterologous epitopes on Staphylococcus xylosus as a potential delivery system for oral vaccination.

  1993cited by this paper
• Expression of foreign proteins on gram-positive commensal bacteria for mucosal vaccine delivery.

  1993cited by this paper
• Cell wall sorting signals in surface proteins of gram‐positive bacteria.

  1993cited by this paper
• Expression of recombinant proteins on the surface of the coagulase-negative bacterium Staphylococcus xylosus

  1992cited by this paper
• Expression of protein F, the fibronectin-binding protein of Streptococcus pyogenes JRS4, in heterologous streptococcal and enterococcal strains promotes their adherence to respiratory epithelial cells

  1992cited by this paper
• Sorting of Protein A to the Staphylococcal Cell Wall

  1992cited by this paper
• Delivery and expression of a heterologous antigen on the surface of streptococci

  1992cited by this paper
• Surface expression of malarial antigens in Salmonella typhimurium: induction of serum antibody response upon oral vaccination of mice.

  1991cited by this paper
• Induction of virus-neutralizing antibodies by bacteria expressing the C3 poliovirus epitope in the periplasm. The route of immunization influences the isotypic distribution and the biologic activity of the antipoliovirus antibodies.

  1990cited by this paper
• Staphylococcus carnosus: a new host organism for gene cloning and protein production.

  1990cited by this paper
• Selective delivery of antigens by recombinant bacteria.

  1989cited by this paper
• Analysis and use of the serum albumin binding domains of streptococcal protein G

  1988cited by this paper
• Improvements of protoplast transformation in Staphylococcus carnosus

  1987cited by this paper
• Region X, the cell-wall-attachment part of staphylococcal protein A.

  1984cited by this paper

• Staphylococcus carnosus: from starter culture to protein engineering platform

  2017cites this paper
• Lactococcus lactis as a live vector: heterologous protein production and DNA delivery systems.

  2011cites this paper
• Development of Mucosal Vaccines Based on Lactic Acid Bacteria

  2009influential citation
• Current Prophylactic and Therapeutic Uses of a Recombinant Lactococcus lactis Strain Secreting Biologically Active Interleukin-12

  2007cites this paper
• Potential and opportunities for use of recombinant lactic acid bacteria in human health.

  2004cites this paper
• Biotechnological applications for surface‐engineered bacteria

  2004cites this paper
• Lactic Acid Bacteria as Mucosal Delivery Vehicles

  2003cites this paper
• Fluorescence-Activated Cell Sorting of Specific Affibody-Displaying Staphylococci

  2003cites this paper
• Vector engineering to improve a staphylococcal surface display system.

  2002cites this paper
• General expression vectors for Staphylococcus carnosus enabled efficient production of the outer membrane protein A of Klebsiella pneumoniae.

  2002cites this paper
• Genetic engineering of Streptococcus gordonii for the simultaneous display of two heterologous proteins at the bacterial surface.

  2002cites this paper
• Display of proteins on bacteria.

  2002cites this paper
• Engineering of staphylococcal surfaces for biotechnological applications.

  2002cites this paper
• Comparison of the immune responses induced by local immunizations with recombinant Lactobacillus plantarum producing tetanus toxin fragment C in different cellular locations.

  2002cites this paper
• Directed immobilization of recombinant staphylococci on cotton fibers by functional display of a fungal cellulose-binding domain.

  2001cites this paper
• Nasal vaccination using live bacterial vectors.

  2001cites this paper
• Edible genetically modified microorganisms and plants for improved health.

  2001cites this paper
• Generation of Metal-Binding Staphylococci through Surface Display of Combinatorially Engineered Cellulose-Binding Domains

  2001cites this paper
• Partial protection to respiratory syncytial virus (RSV) elicited in mice by intranasal immunization using live staphylococci with surface-displayed RSV-peptides.

  2000cites this paper
• Staphylococcal Surface Display of Metal-Binding Polyhistidyl Peptides

  2000cites this paper
• Lactic acid bacteria as live vaccines.

  2000cites this paper
• Anchoring of proteins to lactic acid bacteria

  1999cites this paper
• A surface-displayed cholera toxin B peptide improves antibody responses using food-grade staphylococci for mucosal subunit vaccine delivery.

  1999cites this paper
• Staphylococcal Surface Display of Immunoglobulin A (IgA)- and IgE-Specific In Vitro-Selected Binding Proteins (Affibodies) Based on Staphylococcus aureus Protein A

  1999cites this paper
• Engineering of a Staphylococcus carnosus surface display system by substitution or deletion of a Staphylococcus hyicus lipase propeptide.

  1999cites this paper
• Production of recombinant subunit vaccines: protein immunogens, live delivery systems and nucleic acid vaccines.

  1999cites this paper
• Vaginal Immunization with Recombinant Gram‐Positive Bacteria

  1998cites this paper
• Surface display of the cholera toxin B subunit on Staphylococcus xylosus and Staphylococcus carnosus

  1997cites this paper
• Recombinant Streptococcus gordonii as a Live Vehicle for Vaccine Antigens

  1997cites this paper